title: An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis.
authors: Department of Rheumatology, Addenbrooke's Hospital, Cambridge University NHS Foundation Trust, , Cambridge, UK.
authors: G P R
authors: GP
authors: Clunie
authors: A
authors: A
authors: Ginawi
authors: P
authors: P
authors: O'Conner
authors: P W
authors: PW
authors: Bearcroft
authors: S J
authors: SJ
authors: Garber
authors: S
authors: S
authors: Bhagat
authors: A
authors: A
authors: Grainger
authors: J S H
authors: JS
authors: Gaston
mesh_terms: D000328:Adult; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010000:Osteitis / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D016896:Treatment Outcome; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid
keywords: Ankylosing Spondylitis; Magnetic Resonance Imaging; Treatment